StockData

HealthEquity vs Paymentus

HQY and PAY side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How HQY and PAY compare

HealthEquity is the larger company, worth 2.0 times as much as Paymentus ($8.4B against $4.1B).

On earnings, HealthEquity is cheaper: it trades at 36.8× trailing earnings, against 45.0× for Paymentus.

Paymentus grew revenue faster over the last twelve months (26.5% versus 7.3% for HealthEquity).

HealthEquity keeps more of each dollar of sales as profit, with a net margin of 17.4% compared with 6.7% at Paymentus.

Paymentus scores higher on the StockData Score (18 against 15 for HealthEquity), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricHQYPAY
Size and price
Market cap$8.4B$4.1B
Share price$101.84$32.82
Change, 1 year0.07%−12.9%
Change, 5 years77.5%16.1%
Beta (5Y)0.391.52
Employees2,8141,340
StockData Score
Total score1518 (better)
Valuation score3 (better)2
Growth score35 (better)
Performance score45 (better)
Health score56 (better)
Dividend score00
Valuation
P/E36.8× (better)45.0×
P/S6.2×2.9× (better)
P/B4.2× (better)6.4×
EV/EBITDA17.9× (better)27.2×
P/FCF17.3× (better)24.7×
FCF yield5.8% (better)4.1%
Fair value$110.02$32.56
Margin of safety7.4% (better)−0.79%
Growth
Revenue growth (TTM)7.3%26.5% (better)
Revenue growth, 5Y average12.4%31.7% (better)
Net income growth (TTM)62.2% (better)59.2%
EPS growth (TTM)67.9% (better)58.7%
EPS growth, 5Y average83.0% (better)45.4%
Profitability
Gross margin71.2% (better)25.2%
Operating margin25.8% (better)8.2%
Net margin17.4% (better)6.7%
FCF margin35.8% (better)11.8%
Return on equity11.4%16.0% (better)
Return on invested capital9.8%35.8% (better)
Financial health
Debt / equity0.47 (better)0.00
Net debt / EBITDA1.33–
Interest coverage6.7×–
Current ratio2.994.82 (better)
Altman Z-score4.9024.02 (better)
Piotroski F-score9 (better)7
Dividends and buybacks
Buyback yield4.8%–
Shareholder yield4.8% (better)0.00%
Ownership
Held by institutions109%44.9%
Held by insiders1.4%84.1%
Insider net buying, 12 months−$4.1M (better)−$7.1M
Short interest, % of float6.7%10.9%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.